From the ∗Department of Obstetrics and Gynecology, Seoul National University College of Medicine
†Department of Obstetrics and Gynecology, Seoul National University Hospital
‡Department of Nuclear Medicine, Seoul National University College of Medicine
Departments of §Nuclear Medicine
∥Genomic Medicine, Seoul National University Hospital
¶Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine
∗∗Cancer Research Institute, Seoul National University
††Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Conflicts of interest and sources of funding: The authors have no conflicts of interest to declare. This work was supported by the National Research Foundation of Korea grants funded by the Korea government (MSIT) (NRF-2020R1G1A1005711 and NRF-2020M2D9A1093988).
Received for publication July 19, 2022; revision accepted August 23, 2022.
J.K. and J.G. equally contributed to the manuscript.
Y.S.C. and M.L. contributed equally to the manuscript and share co-senior authorship.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.nuclearmed.com).
Correspondence to: Young Seok Cho, MD, PhD, Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul 06351, South Korea. E-mail: [email protected]; Maria Lee, MD, PhD, Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul 03080, South Korea. E-mail: [email protected].
